ATRA vs KEYS · rev $128.9M vs P/E 57, rev $4.98B
Atara Biotherapeutics Inc (ATRA) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
ATRA currently screens at market cap $87.1M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the ATRA and KEYS stock pages for the full models.
Not investment advice.